Ligand chain length drives activation of lipid G protein-coupled receptors

Sphingosine-1-phosphate (S1P) is a lipid mediator that can activate five cell membrane G protein-coupled receptors (GPCRs) which carry a variety of essential functions and are promising drug targets. S1P is composed of a polar zwitterionic head-group and a hydrophobic alkyl chain. This implies an activation mechanism of its cognate receptor that must be significantly different from what is known for prototypical GPCRs (ie receptor to small hydrophilic ligands). Here we aim to identify the structural features responsible for S1P agonism by combining molecular dynamics simulations and functional assays using S1P analogs of different alkyl chain lengths. We propose that high affinity binding involves polar interactions between the lipid head-group and receptor side chains while activation is due to hydrophobic interactions between the lipid tail and residues in a distinct binding site. We observe that ligand efficacy is directly related to alkyl chain length but also varies with receptor subtypes in correlation with the size of this binding pocket. Integrating experimental and computational data, we propose an activation mechanism for the S1P receptors involving agonist-induced conformational events that are conserved throughout class A GPCRs.

[1]  H. Schiöth,et al.  The Repertoire of G-Protein–Coupled Receptors in Fully Sequenced Genomes , 2005, Molecular Pharmacology.

[2]  Michael D. Davis,et al.  Synthesis and biological evaluation of gamma-aminophosphonates as potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonists. , 2007, Bioorganic & medicinal chemistry.

[3]  Shuguang Yuan,et al.  Lipid Receptor S1P1 Activation Scheme Concluded from Microsecond All-Atom Molecular Dynamics Simulations , 2013, PLoS Comput. Biol..

[4]  Thomas M Frimurer,et al.  A Conserved Aromatic Lock for the Tryptophan Rotameric Switch in TM-VI of Seven-transmembrane Receptors* , 2009, The Journal of Biological Chemistry.

[5]  A. Sali,et al.  Comparative protein structure modeling of genes and genomes. , 2000, Annual review of biophysics and biomolecular structure.

[6]  S. Katsumura,et al.  Versatile synthetic method for sphingolipids and functionalized sphingosine derivatives via olefin cross metathesis. , 2006, Organic letters.

[7]  S. Rasmussen,et al.  Structure of a nanobody-stabilized active state of the β2 adrenoceptor , 2010, Nature.

[8]  J. Ballesteros,et al.  Beta2 adrenergic receptor activation. Modulation of the proline kink in transmembrane 6 by a rotamer toggle switch. , 2002, The Journal of biological chemistry.

[9]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[10]  L. Pardo,et al.  Mechanism of N-terminal modulation of activity at the melanocortin-4 receptor GPCR. , 2012, Nature chemical biology.

[11]  L. Pardo,et al.  Linking agonist binding to histamine H1 receptor activation , 2005, Nature chemical biology.

[12]  H. Hartung,et al.  Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis , 2010, Clinical neuropharmacology.

[13]  Michael D. Davis,et al.  Sphingosine 1-Phosphate Analogs as Receptor Antagonists* , 2005, Journal of Biological Chemistry.

[14]  C. Chalfant,et al.  Sphingolipids as Signaling and Regulatory Molecules , 2010 .

[15]  J. Bockaert,et al.  Molecular tinkering of G protein‐coupled receptors: an evolutionary success , 1999, The EMBO journal.

[16]  Y. Fujiwara,et al.  Identification of the Hydrophobic Ligand Binding Pocket of the S1P1 Receptor* , 2007, Journal of Biological Chemistry.

[17]  Jens Meiler,et al.  Structure of a Class C GPCR Metabotropic Glutamate Receptor 1 Bound to an Allosteric Modulator , 2014, Science.

[18]  Leonardo Pardo,et al.  Influence of the g- conformation of Ser and Thr on the structure of transmembrane helices. , 2010, Journal of structural biology.

[19]  Mihaly Mezei,et al.  Simulaid: A simulation facilitator and analysis program , 2010, J. Comput. Chem..

[20]  B. Kobilka,et al.  Energy landscapes as a tool to integrate GPCR structure, dynamics, and function. , 2010, Physiology.

[21]  Sebastian Funk,et al.  Identifying Transmission Cycles at the Human-Animal Interface: The Role of Animal Reservoirs in Maintaining Gambiense Human African Trypanosomiasis , 2013, PLoS Comput. Biol..

[22]  Jessica Sallander,et al.  Conformational Toggle Switches Implicated in Basal Constitutive and Agonist-Induced Activated States of 5-Hydroxytryptamine-4 Receptors , 2009, Molecular Pharmacology.

[23]  Hugh Rosen,et al.  Crystal Structure of a Lipid G Protein–Coupled Receptor , 2012, Science.

[24]  T. S. Kobilka,et al.  Structural Insights into the Dynamic Process of β2-Adrenergic Receptor Signaling , 2015, Cell.

[25]  Oliver P. Ernst,et al.  Crystal structure of metarhodopsin II , 2011, Nature.

[26]  Michael D. Davis,et al.  Synthesis and biological evaluation of γ-aminophosphonates as potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonists , 2007 .

[27]  S. Rasmussen,et al.  A monoclonal antibody for G protein–coupled receptor crystallography , 2007, Nature Methods.

[28]  J. Wess,et al.  Activation and allosteric modulation of a muscarinic acetylcholine receptor , 2013, Nature.

[29]  Rommie E. Amaro,et al.  POVME 2.0: An Enhanced Tool for Determining Pocket Shape and Volume Characteristics , 2014, Journal of chemical theory and computation.

[30]  Carsten Kutzner,et al.  GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. , 2008, Journal of chemical theory and computation.

[31]  K. Garcia,et al.  Adrenaline-activated structure of the β2-adrenoceptor stabilized by an engineered nanobody , 2013, Nature.

[32]  Manfred Burghammer,et al.  Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. , 2007, Nature.

[33]  James G. Martin,et al.  Sphingosine 1-Phosphate (S1P) Induced Interleukin-8 (IL-8) Release Is Mediated by S1P Receptor 2 and Nuclear Factor κB in BEAS-2B Cells , 2014, PloS one.

[34]  A. Parrill,et al.  S1P1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate. , 2005, Chemistry & biology.

[35]  K. Dev,et al.  The structure and function of the S1P1 receptor. , 2013, Trends in pharmacological sciences.

[36]  Albert C. Pan,et al.  The Dynamic Process of β2-Adrenergic Receptor Activation , 2013, Cell.

[37]  R. Stevens,et al.  Structure of an Agonist-Bound Human A2A Adenosine Receptor , 2011, Science.

[38]  Irina Kufareva,et al.  Chemokine and chemokine receptor structure and interactions: implications for therapeutic strategies , 2015, Immunology and cell biology.

[39]  Christopher G. Tate,et al.  The structural basis for agonist and partial agonist action on a β1-adrenergic receptor , 2010, Nature.

[40]  Arthur J. Olson,et al.  AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..

[41]  R. Proia,et al.  Subcellular Origin of Sphingosine 1-Phosphate Is Essential for Its Toxic Effect in Lyase-deficient Neurons* , 2009, Journal of Biological Chemistry.

[42]  Abby L Parrill,et al.  Molecular recognition in the sphingosine 1-phosphate receptor family. , 2008, Journal of molecular graphics & modelling.

[43]  Steven J Brown,et al.  Sphingosine 1-phosphate receptor signaling. , 2009, Annual review of biochemistry.

[44]  H. Rosen,et al.  Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists , 2002, Science.

[45]  S. Rasmussen,et al.  Crystal Structure of the β2Adrenergic Receptor-Gs protein complex , 2011, Nature.

[46]  D. Im.  Discovery of new G protein-coupled receptors for lipid mediators Published, JLR Papers in Press, December 1, 2003. DOI 10.1194/jlr.R300006-JLR200 , 2004, Journal of Lipid Research.

[47]  L. Pardo,et al.  The pathway of ligand entry from the membrane bilayer to a lipid G protein-coupled receptor , 2016, Scientific Reports.

[48]  S. Spiegel,et al.  Identification of Edg1 Receptor Residues That Recognize Sphingosine 1-Phosphate* , 2000, The Journal of Biological Chemistry.

[49]  M. Burghammer,et al.  Crystal structure of the human β2 adrenergic G-protein-coupled receptor , 2007, Nature.

[50]  Gianluigi Caltabiano,et al.  Impact of Helix Irregularities on Sequence Alignment and Homology Modeling of G Protein‐Coupled Receptors , 2012, Chembiochem : a European journal of chemical biology.

[51]  S. Rees,et al.  A bioluminescent assay for agonist activity at potentially any G-protein-coupled receptor. , 1997, Analytical biochemistry.

[52]  Saskia Nijmeijer,et al.  A Structural Insight into the Reorientation of Transmembrane Domains 3 and 5 during Family A G Protein-Coupled Receptor Activation , 2011, Molecular Pharmacology.

[53]  M. Babu,et al.  Molecular signatures of G-protein-coupled receptors , 2013, Nature.

[54]  Gianluigi Caltabiano,et al.  Membrane Protein Simulations Using AMBER Force Field and Berger Lipid Parameters. , 2012, Journal of chemical theory and computation.

[55]  D. Im.  Intercellular Lipid Mediators and GPCR Drug Discovery , 2013, Biomolecules & therapeutics.

[56]  M. Maceyka,et al.  Extracellular and intracellular actions of sphingosine-1-phosphate. , 2010, Advances in experimental medicine and biology.